FDA says Taylor Farms cyclospora finding was a false positive

BEIJING, July 16, 2026 /PRNewswire/ — Where can you experience Beijing’s performing arts scene in just one day? More places than you might expect. From immersive dining experiences and century-old opera to rooftop concerts and riverside performances, discover how Beijing transforms everyday places into unforgettable stages. Here, culture isn’t something you simply watch—it’s something you…

“High-end buyers are driving demand and prices in much of the country,” said Chen Zhao, Redfin’s head of economics research. “There’s a pool of higher-income buyers who are purchasing seven-figure homes, but a lot of first-time and average move-up buyers are priced out as mortgage rates stay near 6.5%, making monthly payments challenging.”  June’s average…

Corn futures are trading with 7 to 9 cent gains at midday, with spillover support from wheat. The CmdtyView national average Cash Corn price is up 8 1/2 cents at $4.30 3/4. EIA’s weekly Petroleum Status Report showed ethanol production back up 54,000 bpd in the week of 7/17 after the previous drop, to 1.094 million…

Jump Trading has doubled its dedicated prediction markets team this year, as the high-frequency trading firm increases its exposure to one of the fastest-growing corners of event-based trading. Prediction market volumes topped $50 billion in June, drawing increasing participation from institutional trading firms. For Jump, the opportunity is large enough to justify a different kind…

“Purchase application demand has weakened recently, but housing affordability is more favorable and housing inventory continues to rise, thus the backdrop for prospective homebuyers is modestly improving,” Sam Khater, chief economist at Freddie Mac in McLean, Virginia. Geopolitics override an encouraging inflation signal An otherwise promising week for rate watchers was quickly overtaken by events in…

Dr Douglas Williams is a veteran senior executive and board member for several biotech companies. During his time at Biogen, ZymoGenetics, Amgen Immunex and Seattle Genetics, he was involved in the development of several multibillion-dollar treatments, including Enbrel, Tecfidera and Spinraza. Matthew Partridge: The time and cost of clinical trials has been seen as one…